Evonik is one of the world's leading specialty chemicals
companies. Profitable growth and a sustained increase in the value of the
company form the heart of our strategy, which is supported by our owners,
RAG-Stiftung (74.99 percent) and funds managed by CVC Capital Partners (25.01
percent). Our specialty chemicals activities focus on high-growth
megatrends—especially health, nutrition, resource efficiency, and
globalization—and our goal is to enter attractive future-oriented markets.
In 2011 Evonik’s roughly 33,000 employees generated sales of €14.5 billion and an operating result (EBITDA) of €2.8 billion. More than 70 percent of sales are generated outside Germany, providing convincing evidence that our business is global.
In 2011 Evonik’s roughly 33,000 employees generated sales of €14.5 billion and an operating result (EBITDA) of €2.8 billion. More than 70 percent of sales are generated outside Germany, providing convincing evidence that our business is global.
The Aquaculturists
This blog is maintained by The Aquaculturists staff and is supported by the
magazine International Aquafeed which is published by Perendale Publishers Ltd
For additional daily news from aquaculture around the world: aquaculture-news
No comments:
Post a Comment